Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review).


Journal

Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 08 03 2024
accepted: 14 05 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: ppublish

Résumé

Breast cancer, a prominent cause of mortality among women, develops from abnormal growth of breast tissue, thereby rendering it one of the most commonly detected cancers in the female population. Although numerous treatment strategies are available for breast cancer, discordance in terms of effective treatment and response still exists. Recently, the potential of signaling pathways and transcription factors has gained substantial attention in the cancer community; therefore, understanding their role will assist researchers in comprehending the onset and advancement of breast cancer. Forkhead box (FOX) proteins, which are important transcription factors, are considered crucial regulators of various cellular activities, including cell division and proliferation. The present study explored several subclasses of FOX proteins and their possible role in breast carcinogenesis, followed by the interaction between microRNA (miRNA) and FOX proteins. This interaction is implicated in promoting cell infiltration into surrounding tissues, ultimately leading to metastasis. The various roles that FOX proteins play in breast cancer development, their intricate relationships with miRNA, and their involvement in therapeutic resistance highlight the complexity of breast cancer dynamics. Therefore, recognizing the progress and challenges in current treatments is crucial because, despite advancements, persistent disparities in treatment effectiveness underscore the need for ongoing research, with future studies emphasizing the necessity for targeted strategies that account for the multifaceted aspects of breast cancer.

Identifiants

pubmed: 38847267
doi: 10.3892/or.2024.8751
pii: 92
doi:
pii:

Substances chimiques

Forkhead Transcription Factors 0
MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sadaf Anwar (S)

Department of Biochemistry, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.

Mubashir Zafar (M)

Department of Family and Community Medicine, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.

Malik Asif Hussain (MA)

Department of Pathology, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.

Naveed Iqbal (N)

Department of Obstetrics and Gynecology, College of Medicine, University of Ha'il 2440, Saudi Arabia.

Abrar Ali (A)

Department of Ophthalmology, College of Medicine, University of Ha'il 2440, Saudi Arabia.
Department of Biotechnology, Jamia Millia Islamia, New Delhi 110025, India.

Simran Kaur (S)

School of Biosciences, Apeejay Stya University, Sohna, Gurugram, Haryana 122103, India.

Mohammad Zeeshan Najm (MZ)

School of Biosciences, Apeejay Stya University, Sohna, Gurugram, Haryana 122103, India.

Mohd Adnan Kausar (MA)

Department of Biochemistry, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH